🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Open Vs. Endoscopic Transversus Abdominis Release Trial

RecruitingNAAges 18 Years - 90 YearsAllCity Clinical Hospital No.1 named after N.I. Piro…
NCT06195332 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to comparatively evaluate the early and long-term results of open and endoscopic TAR procedure for large midline incisional ventral hernias.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * midline incisional hernia * defect width from 8 till 12 cm * ASA I-III class * able to give informed consent * elective hernia repair * considered eligible for minimally invasive ventral hernia repair Exclusion Criteria: * primary ventral hernia * lateral hernia with/without midline * refuse to give informed consent
💊

What it tests

  • open TAR
  • endoscopic TAR
📍

Where

1 site
Clinical City Hospital #1 named after N.I. Pirogov
Moscow, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy